2016
DOI: 10.1016/j.bbalip.2016.02.023
|View full text |Cite
|
Sign up to set email alerts
|

Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
1
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
1

Relationship

5
3

Authors

Journals

citations
Cited by 37 publications
(32 citation statements)
references
References 38 publications
1
29
1
1
Order By: Relevance
“…Recent studies reported the impact of tuberous sclerosis complex 1 (Tsc1 ) loss on WAT and BAT7879. Because the loss of TSC1 constitutively activates mTORC1, it would be expected that these studies would show results that oppose our findings.…”
Section: Discussioncontrasting
confidence: 69%
See 1 more Smart Citation
“…Recent studies reported the impact of tuberous sclerosis complex 1 (Tsc1 ) loss on WAT and BAT7879. Because the loss of TSC1 constitutively activates mTORC1, it would be expected that these studies would show results that oppose our findings.…”
Section: Discussioncontrasting
confidence: 69%
“…Because the loss of TSC1 constitutively activates mTORC1, it would be expected that these studies would show results that oppose our findings. Accordingly, Adiponectin-cre mediated recombination of Tsc1 increased BAT mass, an effect associated with a trend towards higher BAT DNA content78. The impact of cold on BAT mass expansion and metabolism was not tested in this report.…”
Section: Discussionmentioning
confidence: 79%
“…Elevated mTORC1 signaling resulting from the deletion of tuberous sclerosis complex 2 (Tsc2), a complex made up of Tsc1 and Tsc2 proteins that inhibits mTORC1 signaling, led to increased adipogenesis in mouse fibroblasts and 3T3-L1 adipocytes ). However, in vivo constitutive activation of mTORC1 in adipocytes by Tsc1 deletion did not induce adipocyte hypertrophy, but instead led to reduced VAT mass, reduced VAT adipocyte number and reduced VAT adipocytes diameter without affecting SAT, pointing to the complex nature of mTORC1 signaling in adipocytes (Magdalon et al, 2016). Taken together, these results show that mTORC1 depletion leads to adipose atrophy, although conclusive evidence of a role for mTORC1 in adipocyte hypertrophy has not been fully elucidated.…”
Section: Cellular Mechanisms Hypothesized To Regulate Adipose Morphologysupporting
confidence: 54%
“…To address the specificity of rapamycin’s effect in vivo, both studies used Raptor Adipoq-Cre mice to show that Ucp1 cannot be induced by cold [76, 77] or βAR3-agonists [76, 77] without functional mTORC1 in WAT. In agreement, another recent study finds that activating mTORC1 in WAT by deleting its negative regulator TSC1 ( Tsc1 Adipoq-Cre mice) elevates Ucp1, PGC-1α, and PPARα levels [81]. In cultured adipocytes, βAR agonists were also shown to stimulate S6K but not AKT phosphorylation, suggesting a link between mTORC1 and protein kinase A (PKA) signaling [77].…”
Section: Mtorc1 In Brown Adipocytes and The “Browning Of Wat”mentioning
confidence: 69%